Discovery of Novel Diarylamide <i>N</i>-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity
Tubulin has been regarded as an attractive and successful molecular target in cancer therapy and drug discovery. Vicinal diaryl is a simple scaffold found in many colchicine site tubulin inhibitors, which is also an important pharmacophoric point of tubulin binding and anti-cancer activity. As the c...
Main Authors: | Xu Liu, Xiao-Jing Pang, Yuan Liu, Wen-Bo Liu, Yin-Ru Li, Guang-Xi Yu, Yan-Bing Zhang, Jian Song, Sai-Yang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/13/4047 |
Similar Items
-
In Silico Conformation of the Drug Colchicine into Tubulin Models and Acute Phytotoxic Activity on <i>Cucumis sativus</i> Radicles
by: Omar Aristeo Peña-Morán, et al.
Published: (2022-07-01) -
Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE
by: Sofia Nolasco, et al.
Published: (2021-04-01) -
Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors
by: Riham I. Ahmed, et al.
Published: (2017-01-01) -
Interaction of Colchicine-Site Ligands With the Blood Cell-Specific Isotype of β-Tubulin—Notable Affinity for Benzimidazoles
by: Felipe Montecinos, et al.
Published: (2022-05-01) -
Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
by: Laura Gallego-Yerga, et al.
Published: (2021-01-01)